Legal

Found 7,817 articles

• New National Agreement Between Kaiser Permanente and the Alliance of Health Care Unions Ratified

  11/15/2018

  A new 3-year collective bargaining agreement between Kaiser Permanente and the Alliance of Health Care Unions is now in effect through September 30, 2021.

• DOJ Lawsuit Ends with No Financial Penalty or Admission of Wrongdoing for Atrium Health

  11/15/2018

  Atrium Health, the U.S. Department of Justice (DOJ) and the North Carolina Office of Attorney General have reached a settlement agreement that brings an end to litigation over language in certain health insurance contracts.

• Axonics® Granted Seven U.S. Utility Patents Related to its Implantable Sacral Neuromodulation Technology

  11/15/2018

  The U.S. patents issued range in subject matter and include coverage of the Axonics clinician programmer, patient remote control, and internal system electronics.

• 

  New Jersey Sues Janssen Pharmaceuticals Over Two Opioid Drugs

  11/14/2018

  The Garden State joins a long list of governments that have brought charges against opioid makers during an addiction crisis that claims the lives of 116 Americans per day.

• MiMedx Whistleblower, Represented by Halunen Law, Speaks Out

  11/14/2018

  Mike Fox, a client of Halunen Law, was a successful executive for MiMedx, a biopharmaceutical company that manufactures and sells regenerative and therapeutic biologics.

• Bio-Rad and the University of Chicago Win Patent Infringement Case Against 10X Genomics Related to Droplet Microfluidics Technologies

  11/14/2018

  The jury unanimously found that all Single Cell and Linked-Read genomics products sold by 10X Genomics willfully infringed the patents owned by the University of Chicago and licensed to Bio-Rad.

• Bay Area Lyme Foundation Endorses First Recommendations of New HHS Working Group Focused on Tick Borne Diseases

  11/14/2018

  The Foundation encourages Congress to support the recommendations to fund efforts to increase scientific understanding of Lyme disease and other tick-borne infections

• Nu-Med Plus’ Proprietary Technology Aims to Increase Longevity and Safety of Banked Blood Supply and Reduce Side Effects of Blood Transfusions

  11/14/2018

  Patent application on the new device which is designed to pretreat stored blood products with nitric oxide prior to patient transfusions.

• Advisory - Several children's strawberry-flavoured acetaminophen syrups recalled because of defective child-resistant safety caps on the bottles

  11/14/2018

  Laboratoire Riva Inc. and Laboratoires Trianon Inc. are voluntarily recalling several over-the-counter children's strawberry-flavoured acetaminophen syrups labeled as Biomedic, Option+, or Laboratoires Trianon Inc.

• FDA warns StemGenex Biologic Laboratories LLC of illegally marketing an unapproved cellular product manufactured in a facility with significant manufacturing violations, putting patients at risk

  11/13/2018

  The U.S. Food and Drug Administration has warned StemGenex Biologic Laboratories LLC (StemGenex) of San Diego, Calif; its owner/manager Rita F. Alexander and laboratory and medical director Jenny R. Galloway, M.D. about marketing a purported stem cell product without FDA approval and for significant deviations from current good manufacturing practice requirements, including some that could lead to microbial contamination, putting patients at risk.

• athenahealth (ATHN) Alert: Johnson Fistel Investigates Proposed Sale of athenahealth, Inc.; Is $135 a Fair Price?

  11/13/2018

  Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of athenahealth, Inc. breached their fiduciary duties in connection with the proposed sale of the Company to Veritas Capital ("Veritas") and Evergreen Coast Capital ("Evergreen").

• Mesothelioma Victims Center Now Urges Any Shipyard Worker or Navy Veteran with Mesothelioma to Call for Direct Access to Top Attorneys Who Get the Best Financial Settlement Results

  11/13/2018

  The Mesothelioma Victims Center is appealing to a shipyard worker or Navy Veteran who has recently been diagnosed with mesothelioma and inviting them, or their family, to call them anytime at 800-714-0303.

• SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amarin Corporation - AMRN

  11/13/2018

  Pomerantz LLP is investigating claims on behalf of investors of Amarin Corporation plc ("Amarin" or the "Company") (NASDAQ: AMRN).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

• Collidion Announces Settlement of Sonoma Litigation

  11/12/2018

  In 2017, Sonoma filed a lawsuit against Collidion, Hojabr Alimi, Sameer Harish, and Monica Shaffer in federal district court, alleging the misappropriation of its trade secrets and confidential and proprietary information relating to hypochlorous acid products.

• Avandia drug Canada-wide settlement reached

  11/12/2018

  The Avandia drug class action lawsuit has reached a Canada-wide settlement

• One Step Closer to Being Federally Recognized to Accept Medicare / Medicaid and Tricare

  11/12/2018

  Physicians Premier ER Supports the Emergency Room Improvement Act (S. 3531) Introduced to Congress in October 2018

• Hagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVie's Humira Sales Practices

  11/9/2018

   Hagens Berman Sobol Shapiro LLP reminds investors in AbbVie Inc. (NYSE: ABBV) of the Firm's ongoing investigation of AbbVie's Humira sales practices.

• American College of Chest Physicians Disagrees with FDA Decision to Approve Over-the-Counter Epinephrine for the Treatment of Asthma

  11/9/2018

  The American College of Chest Physicians (CHEST) is disappointed with the FDA's decision to approve over-the-counter epinephrine (Primatene Mist HFA) for the treatment of asthma.

• Response to HHS Secretary Azar's comments on a radiation oncology alternative payment model

  11/8/2018

  Following comments today from Alex Azar, the Secretary of Health and Human Services, on an alternative payment model for radiation oncology, the American Society for Radiation Oncology (ASTRO) issued the following statement from CEO Laura Thevenot

• FITBIT DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Fitbit, Inc. To Contact The Firm

  11/8/2018

  Faruqi & Faruqi, LLP reminds investors in Fitbit, Inc. of the December 31, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.